How do I administer NovoMix 30 (insulin aspart protamine suspension) subcutaneously?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Use NovoMix 30 FlexPen

Inject NovoMix 30 subcutaneously using a 4-mm pen needle at a 90° angle immediately before breakfast and dinner, after gently rolling the pen 10 times and tipping it up and down 10 times to resuspend the cloudy insulin. 1, 2

Pre-Injection Preparation

Insulin Resuspension (Critical for NovoMix 30)

  • Gently roll the pen horizontally between your palms 10 times, then tip it up and down 10 times until all white crystals are fully dissolved and the insulin appears uniformly cloudy 1
  • Never shake the pen vigorously, as this creates air bubbles that affect dose accuracy 3
  • The insulin should look uniformly white and cloudy after mixing; do not use if it remains clear or has clumps 2

Temperature and Storage

  • Remove the pen from the refrigerator 30–60 minutes before injection to allow it to reach room temperature, which reduces pain and prevents lipodystrophy 3, 1
  • Store unopened pens in the refrigerator at 36°F to 46°F (2°C to 8°C) until the expiration date 2
  • Once opened, store at room temperature below 86°F (30°C) and discard after 14 days, even if insulin remains 2

Hand Hygiene and Site Inspection

  • Wash your hands thoroughly before handling the pen 1
  • Visually inspect the injection site for redness, swelling, lumps, or wounds—never inject into abnormal areas 1

Needle Attachment and Priming

  • Attach a new 4-mm pen needle before every injection—never reuse needles, as they lose sterility and become damaged 1, 4
  • Prime the pen by dialing 2 units and pressing the button until at least one drop of insulin appears at the needle tip to verify free flow and ensure accurate dosing 1, 4
  • Remove the needle immediately after each injection and never leave it attached to the pen, as this causes air contamination and medication leakage 1, 2

Injection Site Selection

Recommended Body Areas

  • Inject into the abdomen (fastest absorption), thighs (upper third anterior lateral aspect), buttocks (posterior lateral aspect), or upper arms (middle third posterior aspect) 1, 5
  • Stay at least 2 fingerbreadths (approximately 1 cm) away from the umbilicus when injecting in the abdomen 1
  • The arm is the least preferred site for self-injection because it is difficult to maintain the proper 90° angle without assistance 3

Site Rotation Strategy

  • Divide each injection area into quadrants or halves and rotate systematically within one area before moving to another, using one zone quadrant/half per week 1, 5
  • Inject at least 1 cm (one finger-width) from the previous injection site, rotating in a consistent direction 3, 1
  • Systematic rotation prevents lipohypertrophy (lumpy tissue), which causes unpredictable insulin absorption and poor glucose control 1, 5

Injection Technique

Needle Insertion

  • Hold the pen perpendicular to the skin at a 90° angle 1
  • Insert the 4-mm needle fully in one smooth motion 1
  • For very thin adults, young children (≤6 years), or pregnant individuals, gently lift a skin-fold without blanching before insertion to ensure subcutaneous delivery 1

Dose Delivery

  • Do not press the thumb button until the needle is fully inserted into the skin 1, 4
  • Press the thumb button straight down along the pen's axis (not at an angle), injecting slowly and steadily 1
  • After the button is fully depressed, count slowly to 10 while maintaining pressure on the button and keeping the needle embedded in the skin to ensure complete dose delivery 1, 4

Needle Removal and Disposal

  • Withdraw the needle straight out without pressing the skin 1
  • Discard the needle immediately in a puncture-resistant sharps container without recapping 1, 2
  • Never share pens or needles between patients, as this transmits blood-borne infections 1, 2

Post-Injection Care

  • If a small amount of blood or fluid appears, blot gently with gauze—do not rub or apply pressure 1
  • Do not apply bandages or pressure to the injection site 1
  • Occasional bruising does not affect insulin absorption 1
  • Avoid touching, scratching, or applying lotions for several hours; gentle washing with soap and water after 1 hour is permissible 1

Storage and Maintenance

  • Store the pen without the needle attached to prevent leaking, needle blockage, and air entry 2
  • Never freeze NovoMix 30; discard if it has been frozen 2
  • Keep the pen away from heat and direct sunlight 3, 2
  • Clean the outside of the pen by wiping with a damp cloth—do not soak or wash it 2
  • Discard the pen after 14 days of use at room temperature, even if insulin remains 2

Critical Safety Pitfalls to Avoid

  • Never inject into areas with lipohypertrophy (lumps or firm tissue), as this causes slower and unpredictable absorption 1, 5
  • Never inject through clothing 3
  • Never reuse needles—they lose sterility and may become bent or hooked, causing tissue damage 1, 4
  • Never leave needles attached between injections, as this distorts dose accuracy 4, 2
  • Intramuscular injection causes unpredictable, faster insulin absorption leading to unexpected hypoglycemia—always use 4-mm needles at 90° to ensure subcutaneous delivery 1
  • Have all injection sites inspected by your healthcare provider at every visit, or at least annually 5

References

Guideline

Guidelines for Subcutaneous Injection Technique and Safety

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Maximum Insulin Dose in Pen Devices: Safety and Effectiveness Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Insulin Injection Site Rotation and Technique

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

How should I manage an adult patient whose blood glucose is 150–350 mg/dL despite using only a sliding‑scale insulin regimen?
What is the relationship between atherosclerotic plaque development and insulin spikes in diabetes?
What is the appropriate next management for an 81‑year‑old woman with type 2 diabetes, hemoglobin A1c 6.9%, impaired renal function (elevated BUN, reduced eGFR) and significant albuminuria/proteinuria who is currently taking atenolol, aspirin, atorvastatin, gabapentin, insulin, semaglutide, and valsartan (Diovan)?
What is the ideal self‑monitoring of blood glucose (SMBG) schedule to assess adequacy of treatment with pre‑meal NovoMix 30 (insulin aspart protamine/insulin aspart) pen insulin?
Is it safe to increase my twice-daily basal insulin glargine (Lantus) from 15 units each dose to 20–25 units each dose in uncontrolled diabetes mellitus?
Is pneumonia an infectious condition?
In a woman with intermittent ten‑minute anal pain provoked by straining, can long‑standing severe reactive hypoglycemia trigger proctalgia fugax?
What are the electrocardiogram (ECG) changes observed in myocardial infarction (MI)?
What are the physical examination findings associated with a left atrial myxoma?
Can pneumonia be transmitted via airborne (aerosol) spread?
How should a 47‑year‑old woman with known hyperthyroidism, intermittently taking propylthiouracil (PTU) due to financial constraints, presenting with one month of neck pain, chest discomfort, occasional palpitations, sinus rhythm on electrocardiogram, cardiomegaly on chest X‑ray, normal serum sodium and creatinine, normal thyroid‑stimulating hormone and free triiodothyronine, and mildly elevated free thyroxine be managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.